SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Cash Cat

Cash Cat is generating significant community buzz following its listing on the Robinhood platform, with traders actively debating its potential as a leading meme coin on the new chain. While some participants are aggressively accumulating the token in anticipation of further momentum, others are monitoring the broader rotation of speculative capital and ongoing price volatility.

Berkshire Hathaway, Inc. is a holding company, which engages in the provision of property and casualty insurance and reinsurance, utilities and energy, freight rail transportation, finance, manufacturing, and retailing services. It operates through the following segments: Insurance, Burlington Northern Santa Fe, LLC (BNSF), Berkshire Hathaway Energy (BHE), Pilot Travel Centers (PTC), Manufacturing, McLane, and Service and Retailing. The Insurance segment includes the underwriting of GEICO, Berkshire Hathaway Primary Group, and Berkshire Hathaway Reinsurance Group. The BNSF segment involves the operation of railroad systems. The BHE segment focuses on regulated electric and gas utility, power generation and distribution, and real estate brokerage activities. The PTC segment consists of managing travel centers and marketing of wholesale fuel. The Manufacturing segment refers to industrial, consumer and building products, home building, and related financial services. The McLane segment covers the wholesale distribution of groceries and non-food items. The Service and Retailing segment relates to the provision of shared aircraft ownership programs, aviation pilot training, electronic components distribution, retailing businesses, automobile dealerships and trailer, and furniture leasing services. The company was founded by Oliver Chace in 1839 and is headquartered in Omaha, NE.

Berkshire Hathaway Inc. - Ordinary Shares - Class B

Berkshire Hathaway is trending as investors digest a strong earnings report showing a significant rise in operating profits and the company's shift toward net equity buying for the first time in years. The community is actively debating the effectiveness of the leadership's capital deployment strategy, balancing the firm's massive cash position against its recent investments in tech-focused equities and share buybacks.

Venture Global, Inc. engages in the provision of United States liquefied natural gas sourced from resource rich North American natural gas basins. It operates through the following segments: Calcasieu Project, Plaquemines Project, CP2 Project, and Sales and shipping. The company was founded by Michael Sabel and Robert Pender in 2023 and is headquartered in Arlington, VA.

Venture Global Inc. - Ordinary Shares - Class A

Venture Global Inc

Venture Global is trending as investors weigh significant geopolitical disruptions in the Strait of Hormuz against ongoing market volatility driven by algorithmic trading and energy sector rotations. The community is actively discussing the company's long-term infrastructure expansion and potential for massive cash flow generation, while debating whether current price action is a temporary manipulation or reflective of broader commodity market instability.

United Parcel Service, Inc. is a package delivery company, which engages in the provision of global supply chain management solutions. It operates through the following segments: U.S. Domestic Package and International Package. The U.S. Domestic Package segment includes time-definite delivery of letters, documents, and packages. The International Package segment focuses on delivery and shipments in Europe, Asia, the Indian sub-continent, the Middle East, Africa, Canada, and Latin America. The company was founded by James E. Casey and Claude Ryan on August 28, 1907 and is headquartered in Atlanta, GA.

United Parcel Service, Inc. - Ordinary Shares - Class B

United Parcel Service, Inc.

UPS is currently drawing significant investor attention as a defensive play following a series of strategic cost-cutting initiatives and a commitment to maintaining its dividend, though the stock faces ongoing scrutiny over labor expenses and stiff competition. Community members are actively debating the long-term impact of potential operational shifts against the backdrop of broader logistics sector pressures and dividend reliability.

Xeris Biopharma Holdings, Inc. is a biopharmaceutical company, which engages in developing and commercializing products across a range of therapies. Its products include Gvoke, Keveyis, and Recorlev. Gvoke is a ready-to-use liquid glucagon for the treatment of severe hypoglycemia. Keveyis is the therapy approved in the United States to treat hyperkalemic, hypokalemic, and related variants of primary periodic paralysis (PPP). Recorlev is a cortisol synthesis inhibitor approved for the treatment of endogenous hypercortisolemia in adult patients with Cushing’s syndrome. The company was founded by Steven Prestrelski in 2005 and is headquartered in Chicago, IL.

Xeris Biopharma Holdings Inc

Xeris Biopharma is trending as investors await the upcoming investor webinar and phase 3 trial details for XP-8121, viewed by many as a potential blockbuster in the endocrinology space. Community sentiment remains focused on the company's strong financial indicators, such as debt reduction and revenue growth, leading to active speculation about both long-term holding potential and possible M&A activity.

Berkshire Hathaway Inc. - Ordinary Shares - Class A

Berkshire Hathaway is trending following reports that the conglomerate has initiated a significant new stake in Alphabet, fueling speculation about the company's long-term strategy in AI and its broader capital deployment efforts. The community is actively discussing the investment's potential as a signal of confidence in the tech sector, while debating the firm's evolving management approach as it prepares for its leadership transition.

Revolution Medicines, Inc. is a clinical-stage precision oncology company, which engages in developing novel targeted therapies. It engages in the discovery and development of cancer treatment by pioneering novel combination and monotherapy treatment regimens to maximize the depth and durability of clinical benefit and circumvent adaptive resistance mechanisms for patients which are dependent on the RAS and mTOR pathway. The company was founded by Mark A. Goldsmith, Kevan Shokat, Martin D. Burke, David L. Pompliano and Michael Fischbach in October 2014 and is headquartered in Redwood City, CA.

Revolution Medicines Inc

Revolution Medicines is experiencing significant momentum as investors digest the recent clinical success of its lead RAS(ON) inhibitor in metastatic pancreatic cancer, which demonstrated an unprecedented improvement in overall survival. The community is heavily focused on the stock's potential as a major acquisition target, with active discussions comparing its robust pipeline and valuation to other oncology innovators and speculating on the timing of a potential buyout.

CVS Health Corp. is a health solutions company, which engages in the provision of healthcare services. It operates through the following segments: Health Care Benefits, Health Services, Pharmacy and Consumer Wellness, and Corporate and Other. The Health Care Benefits segment operates as a health care benefits provider. The Health Services segment offers a full range of PBM solutions, delivers health care services in its medical clinics, virtually, and in the home. The Pharmacy & Consumer Wellness segment dispenses prescriptions in its retail pharmacies and through its infusion operations. The Corporate and Other Segment is involved in management and administrative expenses. The company was founded by Stanley P. Goldstein and Ralph Hoagland in 1963 and is headquartered in Woonsocket, RI.

CVS Health Corp

CVS Health is trending as the market digests the company's Q2 earnings beat, which included raised full-year guidance and analyst price target upgrades from firms like UBS and DA Davidson. While investors are debating the long-term outlook for Caremark and overall margin recovery, community discussion is dominated by arguments that the sell-off following earnings was an overreaction driven by algorithmic trading.

Northrop Grumman Corp. engages in the provision of advanced aircraft systems. It operates through the following segments: Aeronautics Systems, Defense Systems, Mission Systems, and Space Systems. The Aeronautics Systems segment is involved in the design, development, production, integration, sustainment, and modernization of advanced aircraft systems for the U.S. Air Force, the U.S. Navy, other U.S. government agencies, and international customers. The Defense Systems segment includes integrated battle management systems, weapons systems and aircraft, and mission systems sustainment and modernization. The Mission Systems segment offers advanced mission solutions and multifunction systems, primarily for the U.S. defense and intelligence community, and international customers. The Space Systems segment delivers end-to-end mission solutions through the design, development, integration, production and operation of space, missile defense, launch and strategic missile systems for national security, civil government, commercial, and international customers. The company was founded by John K. Northrop, Thomas V. Jones, and Kent Kresa in 1939 and is headquartered in Falls Church, VA.

Northrop Grumman Corp.

Northrop Grumman is trending as investors monitor ongoing defense sector rotation driven by sustained geopolitical tensions and the anticipation of higher procurement spending. The community is actively discussing the company's robust contract backlog and evaluating its long-term growth potential against broader aerospace market volatility.

Alpha Tau Medical Ltd. is a clinical-stage oncology therapeutics company, which focuses on the research, development, and commercialization of diffusing alpha-emitters radiation therapy for the treatment of cancer. The firm is involved in the clinical trials at cancer centers with indications that include skin cancer, oral cavity cancer, breast cancer, and pancreatic cancer. The company was founded by Uzi Sofer, Yona Keisari, and Itzhak Kelson in November 2015 and is headquartered in Jerusalem, Israel.

Alpha Tau Medical Ltd

ALPHA TAU MEDICAL LTD

The community is actively tracking Alpha Tau Medical as it approaches a major podium presentation at the AHNS conference, where the company is expected to release trial data combining its Alpha DaRT platform with the immunotherapy drug Keytruda. Investors are highly optimistic about the synergy between these treatments, viewing the upcoming event as a significant catalyst that could further validate the company's oncology pipeline and drive institutional interest.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Pfizer is seeing heightened trading volume and sentiment driven by recent insider buying, an earnings beat with raised guidance, and ongoing speculation regarding potential strategic acquisitions in the oncology space. Community discussion is split between long-term value investors seeking to capitalize on the high dividend yield and traders attempting to navigate the stock's multi-year consolidation range.

Pfizer's Next Weight-Loss Weapon: How Berobenatide Stacks Up Against Novo Nordisk's Wegovy and Eli Lilly's Zepbound

Key PointsPfizer's berobenatide appears to be a promising candidate that could challenge Wegovy and Zepbound...

NVAX Q2 Earnings & Sales Beat Estimates, '26 Sales Outlook Raised

Novavax beat Q2 earnings and revenue estimates, raises its 2026 adjusted revenue outlook, cuts expense guidance and outlines potential Sanofi milestones ahead.

PFE, MRK, SNY, MRNA In Focus As Trump Reportedly Eyes Executive Order On Vaccines And Autism

Equity

The order’s contents remain unclear, and timing could shift, Bloomberg reported, citing people familiar with the matter.


Thursday 8/6 Insider Buying Report: PFE, GBFH

As the saying goes, there are many possible reasons for an insider to sell a stock, but only one reason to buy -- they expect to make money. So let's look at two noteworthy recent insider buys.

On Wednesday, Pfizer's Director, Ronald E. Blaylock, made a $998,821 purchase of PF...

Moderna's mRNA Flu Vaccine Approved By FDA

Moderna's mRNA Flu Vaccine Approved By FDA

 Authored by Rachel Roberts via The Epoch Times,

The U.S. Food and Drug Administration has approved Moderna's flu shot for over-50s, marking the first time the agency has licensed a messenger ribonucleic acid (mRNA) vaccine for seasonal...

Pfizer Q2 Earnings Call Highlights Non-COVID Growth and Cost Cuts

PFE raises its 2026 revenue outlook as non-COVID growth, deeper cost cuts and pipeline catalysts offset weaker COVID demand.

Company News for Aug 5, 2026

Companies In The News Are: ALSN, CLX, AEIS, PFE.

Pfizer, Merck, Amgen Double Down On Cancer And Send Takeover Buzz Around SLS And IBRX Into Overdrive

IBRX and SLS align with Big Pharma’s cancer push, fueling retail partnership and buyout speculation.

Pfizer Says Monthly GLP-1 Candidate Could Rival Tirzepatide on Weight Loss

Pfizer stock rises after beating Q2 estimates and raising its 2026 revenue guidance to up to $62.5B. Get the key earnings takeaways.read more...

Pfizer repels Covid-19 sales tumble to raise 2026 guidance

Pfizer repels Covid-19 sales tumble to raise 2026 guidance...

This account has been verified as an official PFE representative.

Verified Account

Pfizer Inc. is a research-based global biopharmaceutical company, which engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide. The firm works across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases. The company was founded by Charles Pfizer Sr. and Charles Erhart in 1849 and is headquartered in New York, NY.

Pfizer Inc.

Bullish Sentiment

Track PFE stock price, charts, news and real-time market activity on Stocktwits. Join the PFE message board to follow investor discussions, retail trader sentiment, bullish and bearish signals around Pfizer Inc stock.

PFE Stock Price Today - Pfizer Inc News, Charts, Retail Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Feed

News

Sentiment

Earnings

Fundamentals

Info

PFEPfizer Inc

Fundamentals

Connect Stocktwits to ChatGPT

Latest PFE News